Audio long read: Conquering Alzheimer’s — a l...

In this episode:00:24 The quest to count the Amazon's insects07:31 The orcas that exploded a sunfishThe Guardian: Orcas seen ramming prey so hard it explodes may be playing gameTiktok: Orcas vs sunfishSubscribe to Nature Briefing, an unmissable daily round-up of science news, opi ...  Show more

In this episode:00:45 Ancient structures hidden beneath the Amazon’s canopyResearch article: Pärssinen et al.09:15 Research HighlightsNature: It’ll grow on you: live fungi formed into sustainable fashionPhysical Review Fluids: Gourmandie et al.11:48 Tiny fossils represent the ear ...  Show more

This episode explores the current state of research on the multiple likely mechanisms of Alzheimer’s disease as well as promising treatments and diagnostics. A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2309944. 

A new drug, Donanemab, has been hailed as a turning point in the fight against Alzheimer's after a global trial confirms it slows cognitive decline.One trial was shown to have “significantly slowed” the progression of the disease—by 35%.Earlier this year, Lecanemab, the first dru ...  Show more

An experimental device developed by Cognito Therapeutics seeks to slow cognitive decline in Alzheimer’s patients using light and sound. Learn more about your ad choices. Visit podcastchoices.com/adchoices 

A new drug for Alzheimer's disease, called lecanemab, got a lot of attention earlier this year for getting fast-tracked approval based on a clinical trial that included nearly 1,800 people. It was the most diverse trial for an Alzheimer's treatment to date, but still not enough t ...  Show more